Association between emergency department disposition and mortality in patients with COVID-19 acute respiratory distress syndrome

被引:0
|
作者
Lebold, Katie M. [1 ]
Moore, Andrew R. [2 ]
Sanchez, Pablo A. [3 ]
Pacheco-Navarro, Ana E. [2 ]
O'Donnell, Christian [3 ]
Roque, Jonasel [2 ]
Parmer, Caitlin [4 ]
Pienkos, Shaun [2 ]
Levitt, Joseph [2 ]
Collins, William J. [4 ]
Rogers, Angela J. [2 ]
Wilson, Jennifer G. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Emergency Med, Palo Alto, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Palo Alto, CA 94304 USA
[4] Stanford Univ, Divison Hosp Med, Sch Med, Dept Med, Palo Alto, CA USA
关键词
acute respiratory distress syndrome; COVID-19; disposition; emergency department; INTENSIVE-CARE-UNIT; ADMISSION; OUTCOMES; FAILURE; COHORT;
D O I
10.1002/emp2.13192
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
ObjectivesPatients hospitalized for COVID-19 frequently develop hypoxemia and acute respiratory distress syndrome (ARDS) after admission. In non-COVID-19 ARDS studies, admission to hospital wards with subsequent transfer to intensive care unit (ICU) is associated with worse outcomes. We hypothesized that initial admission to the ward may affect outcomes in patient with COVID-19 ARDS.MethodsThis was a retrospective study of consecutive adults admitted for COVID-19 ARDS between March 2020 and March 2021 at Stanford Health Care. Mortality scores at hospital admission (Coronavirus Clinical Characterization Consortium Mortality Score [4C score]) and ICU admission (Simplified Acute Physiology Score III [SAPS-III]) were calculated, as well as ROX index for patients on high flow nasal oxygen. Patients were classified by emergency department (ED) disposition (ward-first vs. ICU-direct), and 28- and 60-day mortality and highest level of respiratory support within 1 day of ICU admission were compared. A second cohort (April 2021-July 2022, n = 129) was phenotyped to validate mortality outcome.ResultsA total of 157 patients were included, 48% of whom were first admitted to the ward (n = 75). Ward-first patients had more comorbidities, including lung disease. Ward-first patients had lower 4C and similar SAPS-III score, yet increased mortality at 28 days (32% vs. 17%, hazard ratio [HR] 2.0, 95% confidence interval [95% CI] 1.0-3.7, p = 0.039) and 60 days (39% vs. 23%, HR 1.83, 95% CI 1.04-3.22, p = 0.037) compared to ICU-direct patients. More ward-first patients escalated to mechanical ventilation on day 1 of ICU admission (36% vs. 14%, p = 0.002) despite similar ROX index. Ward-first patients who upgraded to ICU within 48 h of ED presentation had the highest mortality. Mortality findings were replicated in a sensitivity analysis.ConclusionDespite similar baseline risk scores, ward-first patients with COVID-19 ARDS had increased mortality and escalation to mechanical ventilation compared to ICU-direct patients. Ward-first patients requiring ICU upgrade within 48 h were at highest risk, highlighting a need for improved identification of this group at ED admission.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Association between lung compliance phenotypes and mortality in COVID-19 patients with acute respiratory distress syndrome
    Puah, Ser Hon
    Cove, Matthew Edward
    Phua, Jason
    Kansal, Amit
    Venkatachalam, Jonathen
    Ho, Vui Kian
    Sewa, Duu Wen
    Gokhale, Roshni Sadashiv
    Liew, Mei Fong
    Ho, Benjamin Choon Heng
    Ng, Jensen Jiansheng
    Abisheganaden, John A.
    Leo, Yee Sin
    Young, Barnaby Edward
    Lye, David Chien
    Yeo, Tsin Wen
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2021, 50 (09) : 686 - 694
  • [2] Management of Acute Respiratory Distress Syndrome in COVID-19 Patients
    Segers, J.
    Hadzic, A.
    Van Boxstael, S.
    Van Herreweghe, I
    De Fre, O.
    ACTA ANAESTHESIOLOGICA BELGICA, 2022, 73 (01) : 5 - 14
  • [3] Acute respiratory distress syndrome and pneumothorax in COVID-19 patients
    Hashemian, Seyed Mohammad Reza
    Shafigh, Navid
    Erfani, Raziyeh
    Khoundabi, Batoul
    Miller, James
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2021, 5 (02): : 217 - 221
  • [4] Acute respiratory distress syndrome in COVID-19
    Dadashzadeh, Nahid
    Farshid, Saman
    Valizadeh, Rohollah
    Nanbakhsh, Mohammad
    Rahimi, Mohsen Mohammad
    IMMUNOPATHOLOGIA PERSA, 2020, 6 (02):
  • [5] Impact of COVID-19 on the association between pulse oximetry and arterial oxygenation in patients with acute respiratory distress syndrome
    Nguyen, Lee S.
    Helias, Marion
    Raia, Lisa
    Nicolas, Estelle
    Jaubert, Paul
    Benghanem, Sarah
    Hamou, Zakaria Ait
    Dupland, Pierre
    Charpentier, Julien
    Pene, Frederic
    Cariou, Alain
    Mira, Jean-Paul
    Chiche, Jean-Daniel
    Jozwiak, Mathieu
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Impact of COVID-19 on the association between pulse oximetry and arterial oxygenation in patients with acute respiratory distress syndrome
    Lee S. Nguyen
    Marion Helias
    Lisa Raia
    Estelle Nicolas
    Paul Jaubert
    Sarah Benghanem
    Zakaria Ait Hamou
    Pierre Dupland
    Julien Charpentier
    Frédéric Pène
    Alain Cariou
    Jean-Paul Mira
    Jean-Daniel Chiche
    Mathieu Jozwiak
    Scientific Reports, 12
  • [7] Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19
    Sousa, Adrian
    Lima, Olalla
    Perez-Gonzalez, Alexandre
    Araujo, Alejandro
    Longueira, Rebeca
    Otero, Anton
    Nunez, Marta
    Ramos, Cristina
    Martinez-Lamas, Lucia
    Crespo-Casal, Manuel
    Rubianes, Martin
    Perez-Rodriguez, Maria Teresa
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2023, 31 (06)
  • [8] VARIATION IN MANAGEMENT OF COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME AND ASSOCIATED MORTALITY
    Garcia, Michael
    Johnson, Shelsey
    Sisson, Emily
    Sheldrick, Christopher
    Kumar, Vishakha
    Boman, Karen
    Bansal, Vikas
    Bogojevic, Marija
    Garces, Juan Pablo Domecq
    Lal, Amos
    Gajic, Ognjen
    Kashyap, Rahul
    Walkey, Allan
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 12 - 12
  • [9] Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19
    Denson, Joshua L.
    Gillet, Aaron S.
    Zu, Yuanhao
    Brown, Margo
    Pham, Thaidan
    Yoshida, Yilin
    Mauvais-Jarvis, Franck
    Douglas, Ivor S.
    Moore, Mathew
    Tea, Kevin
    Wetherbie, Andrew
    Stevens, Rachael
    Lefante, John
    Shaffer, Jeffrey G.
    Armaignac, Donna Lee
    Belden, Katherine A.
    Kaufman, Margit
    Heavner, Smith F.
    Danesh, Valerie C.
    Cheruku, Sreekanth R.
    St Hill, Catherine A.
    Boman, Karen
    Deo, Neha
    Bansal, Vikas
    Kumar, Vishakha K.
    Walkey, Allan J.
    Kashyap, Rahul
    JAMA NETWORK OPEN, 2021, 4 (12)
  • [10] DEXAMETHASONE IN COVID-19 PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME. EXPERIENCE FROM A CARDIOLOGY DEPARTMENT
    Spina, M.
    Chiappa, L.
    Avanzini, F.
    Balestri, G.
    Bertocchi, P.
    Campadello, P.
    Corticelli, A.
    Iacuitti, G.
    Moro, C.
    Mollichelli, N.
    Rogacka, R.
    Romano, S.
    Russo, G.
    Saltafossi, D.
    D'Alessandra, Y.
    Piacentini, L.
    Bonfanti, P.
    Colombo, G.
    Achilli, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C41 - C41